| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |